Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 98,030 |
|
|||||
| News | - | ||||||
| Day High | 26.48 | Low High |
|||||
| Day Low | 23.915 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Dianthus Therapeutics Inc | DNTH | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.64 | -2.57% | 24.29 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 26.48 | 23.915 | 26.48 | 24.29 | 24.93 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,676 | 98,030 | US$ 24.91 | US$ 2,441,660 | - | 6.58 - 33.77 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:23:43 | 6 | US$ 24.00 | USD |
Dianthus Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 359.78M | 14.82M | - | 2.83M | -43.56M | -2.94 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Dianthus Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/09/2024 | 15:01 | GlobeNewswire Inc. | Dianthus Therapeutics Highlights Recent Business.. |
| 5/08/2024 | 15:30 | GlobeNewswire Inc. | Dianthus Therapeutics to Participate in the Bank of America.. |
| 5/03/2024 | 15:30 | GlobeNewswire Inc. | Dianthus Therapeutics Announces Inducement Grants Under.. |
| 4/11/2024 | 06:30 | GlobeNewswire Inc. | Dianthus Therapeutics Announces Oral Presentation for.. |
| 4/05/2024 | 15:30 | GlobeNewswire Inc. | Dianthus Therapeutics Announces Inducement Grants Under.. |
| 3/21/2024 | 15:01 | GlobeNewswire Inc. | Dianthus Therapeutics Highlights Recent Business.. |
| 3/07/2024 | 15:30 | GlobeNewswire Inc. | Dianthus Therapeutics Announces Inducement Grant Under.. |
| 2/26/2024 | 06:00 | GlobeNewswire Inc. | Dianthus Therapeutics Announces Initiation of Phase 2 MaGic.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DNTH Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.62 | 27.63 | 23.19 | 24.74 | 110,018 | -0.33 | -1.34% |
| 1 Month | 24.68 | 27.63 | 19.73 | 23.64 | 165,142 | -0.39 | -1.58% |
| 3 Months | 23.36 | 33.77 | 19.73 | 25.69 | 168,513 | 0.93 | 3.98% |
| 6 Months | 11.38 | 33.77 | 6.58 | 23.29 | 111,410 | 12.91 | 113.44% |
| 1 Year | 10.40 | 33.77 | 6.58 | 22.49 | 89,389 | 13.89 | 133.56% |
| 3 Years | 10.40 | 33.77 | 6.58 | 22.49 | 89,389 | 13.89 | 133.56% |
| 5 Years | 10.40 | 33.77 | 6.58 | 22.49 | 89,389 | 13.89 | 133.56% |
Dianthus Therapeutics Description
| Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to extend the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy. The pipeline of the company includes MGTA-117, MGTA-145, and others. |
